Elevation Oncology Stock Equity Positions Weight

ELEV Stock

USD 0.59 0 0.68%

Elevation Oncology fundamentals help investors to digest information that contributes to Elevation Oncology's financial success or failures. It also enables traders to predict the movement of Elevation Stock. The fundamental analysis module provides a way to measure Elevation Oncology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Elevation Oncology stock.

Other Current Liab Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Elevation Oncology Company Equity Positions Weight Analysis

Elevation Oncology's Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.

Stock Percentage

% of Equities

in the fund

More About Equity Positions Weight | All Equity Analysis

Elevation Equity Positions Weight Driver Correlations

Understanding the fundamental principles of building solid financial models for Elevation Oncology is extremely important. It helps to project a fair market value of Elevation Stock properly, considering its historical fundamentals such as Equity Positions Weight. Since Elevation Oncology's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Elevation Oncology's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Elevation Oncology's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Long Term Debt Total	Capital Surpluse
Total Assets		0.85	0.85	-0.8	-0.71	0.74	0.51	0.87	1.0	1.0	0.15	0.41	0.55	0.37	-0.42	-0.42
Total Stockholder Equity	0.85		1.0	-0.72	-0.58	0.5	-0.02	0.98	0.85	0.85	-0.03	0.34	0.43	0.27	-0.32	-0.32
Net Tangible Assets	0.85	1.0		-0.72	-0.58	0.5	-0.02	0.98	0.85	0.85	-0.04	0.34	0.43	0.25	-0.31	-0.31
Net Debt	-0.8	-0.72	-0.72		0.17	-0.74	-0.38	-0.63	-0.81	-0.82	0.34	0.0	0.02	0.0	0.0	0.0
Retained Earnings	-0.71	-0.58	-0.58	0.17		-0.26	-0.36	-0.72	-0.71	-0.7	-0.53	-0.79	-0.93	-0.68	0.78	0.78
Accounts Payable	0.74	0.5	0.5	-0.74	-0.26		0.64	0.51	0.75	0.72	0.28	-0.18	0.22	-0.16	0.18	0.18
Total Liab	0.51	-0.02	-0.02	-0.38	-0.36	0.64		0.06	0.51	0.5	0.32	0.19	0.33	0.16	-0.18	-0.18
Net Invested Capital	0.87	0.98	0.98	-0.63	-0.72	0.51	0.06		0.87	0.87	0.13	0.46	0.6	0.32	-0.4	-0.4
Total Current Assets	1.0	0.85	0.85	-0.81	-0.71	0.75	0.51	0.87		1.0	0.15	0.41	0.55	0.37	-0.42	-0.42
Net Working Capital	1.0	0.85	0.85	-0.82	-0.7	0.72	0.5	0.87	1.0		0.1	0.42	0.53	0.37	-0.43	-0.43
Intangible Assets	0.15	-0.03	-0.04	0.34	-0.53	0.28	0.32	0.13	0.15	0.1		0.11	0.64	0.23	-0.22	-0.22
Common Stock	0.41	0.34	0.34	0.0	-0.79	-0.18	0.19	0.46	0.41	0.42	0.11		0.78	0.55	-0.75	-0.75
Property Plant Equipment	0.55	0.43	0.43	0.02	-0.93	0.22	0.33	0.6	0.55	0.53	0.64	0.78		0.43	-0.59	-0.59
Long Term Debt	0.37	0.27	0.25	0.0	-0.68	-0.16	0.16	0.32	0.37	0.37	0.23	0.55	0.43		-0.96	-0.96
Long Term Debt Total	-0.42	-0.32	-0.31	0.0	0.78	0.18	-0.18	-0.4	-0.42	-0.43	-0.22	-0.75	-0.59	-0.96		1.0
Capital Surpluse	-0.42	-0.32	-0.31	0.0	0.78	0.18	-0.18	-0.4	-0.42	-0.43	-0.22	-0.75	-0.59	-0.96	1.0

Click cells to compare fundamentals

Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.

Competition

Predict Elevation Oncology

According to the company disclosure, Elevation Oncology has an Equity Positions Weight of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Insider Screener Now

Insider Screener

Find insiders across different sectors to evaluate their impact on performance

All Next

Launch Module

Elevation Fundamentals

	Return On Equity	-0.64
	Return On Asset	-0.25
	Current Valuation	(36.96 M)
	Shares Outstanding	59.12 M
	Shares Owned By Insiders	0.26 %
	Shares Owned By Institutions	83.85 %
	Number Of Shares Shorted	6.15 M
	Price To Earning	0.16 X
	Price To Book	0.51 X
	EBITDA	(41.47 M)
	Net Income	(45.7 M)
	Cash And Equivalents	122.54 M
	Cash Per Share	5.26 X
	Total Debt	30.14 M
	Current Ratio	6.48 X
	Book Value Per Share	1.17 X
	Cash Flow From Operations	(56.18 M)
	Short Ratio	8.55 X
	Earnings Per Share	(0.80) X
	Target Price	7.0
	Number Of Employees	29
	Beta	1.25
	Market Capitalization	35.09 M
	Total Asset	89.09 M
	Retained Earnings	(195.97 M)
	Working Capital	83.82 M
	Net Asset	89.09 M

About Elevation Oncology Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Elevation Oncology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elevation Oncology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elevation Oncology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Elevation Stock Analysis

When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC